Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
    Issue date:2017-10-27
  • Snibe Shows Great Charms at 71th AACC

    Snibe brings the latest innovation MAGLUMI X8 to 71st AACC Annual Scientific Meeting & Clinical Lab Expo, with booth No. 1317 in California United States, one of the largest and most influential medical exhibitions across the world, attracting more than 21,000 visitors, and 800 exhibitors dedicated to sharing the most advanced technology available in the IVD, and medical laboratory market.
    Issue date:2019-08-13
  • Snibe becomes the 1st in China who receives Anti-HCV CLIA Assays List A CE Mark

    July 2019, with the approval of CE mark for Anti-HCV CLIA assay, Snibe has become the 1st company in China to receive CE List A certification for Hepatitis C testing kit In CLIA field.
    Issue date:2019-07-26

About Us

To Be Global IVD Pioneer

Focus On Chemiluminescence Immunoassay For 24years

144Countries

11000Units

More
江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果 江苏快三开奖结果